United States · Series C startup
7 rounds we have observed, with the 12 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$95Mraised across 7 rounds since 2008, from 7 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Atlas Venture
Boulder Ventures
Brace PharmaFrom a historical funding recordSEC filing: $25M sold, first sale Oct 2015
From a historical funding recordSEC filing: $8.5M sold, first sale Feb 2015
From a historical funding recordSEC filing: $13M sold, first sale Apr 2012
Reported by finsmes.comSEC filing: $6.0M sold, first sale Apr 2012
No investor was named in the report.
Reported by sec.govSEC filing: $6.0M sold, first sale Sept 2010
Reported by biospace.comSEC filing: $53K sold, first sale May 2009
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Boulder VenturesAtlas VentureRemeditex VenturesAmgen VenturesAmgenBroadview Ventures
Longview VenturesJAFCO JapanMP Healthcare Venture ManagementBrace PharmaMissing a round, or an investor who was in one? Tell us.
Miragen Therapeutics's investors include Boulder Ventures, Atlas Venture, Remeditex Ventures, Amgen Ventures and Amgen, and 7 more on record.
Miragen Therapeutics has raised $95M across 7 rounds since 2008.
Miragen Therapeutics's most recent round was a Series C of $41M in Nov 2015.
Its most recent round, $41M in Nov 2015, is also its largest on record.
Miragen Therapeutics's first round on record, in May 2008, was backed by Atlas Venture and Boulder Ventures.
Miragen Therapeutics's latest named round is a Series C, in Nov 2015.
Miragen Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States ·